The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - AstraZeneca; Merck Sharp & Dohme; Roche
LEAP-012 trial in progress: Transarterial chemoembolization (TACE) with or without lenvatinib plus pembrolizumab for intermediate-stage hepatocellular carcinoma (HCC)
 
Anthony B. El-Khoueiry
Honoraria - ABL bio; Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; QED Therapeutics; Roche/Genentech
Consulting or Advisory Role - ABL Bio; Agenus; AstraZeneca/MedImmune; Bayer; Bristol-Myers Squibb; CytomX Therapeutics; Eisai; EMD Serono; Exelixis; Gilead Sciences; Merck; Pieris Pharmaceuticals; QED Therapeutics; Roche
Research Funding - Astex Pharmaceuticals; AstraZeneca; Fulgent Genetics
 
Josep M Llovet
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Celsion; Eisai; Exelixis; Genentech; Glycotest; Ipsen; Lilly; Merck; Mina Alpha Ltd; Nucleix; Roche; Sirtex Medical
Research Funding - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai
Travel, Accommodations, Expenses - Bayer
 
Arndt Vogel
Honoraria - Amgen; Bristol-Myers Squibb; Ipsen; Janssen; Lilly; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bayer; BTG; Eisai; IPSEN; Lilly; Novartis; Pierre Fabre; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
David C. Madoff
Stock and Other Ownership Interests - RenovoRx
Consulting or Advisory Role - Boston Scientific; Guerbet; Quantum Surgical
Travel, Accommodations, Expenses - Boston Scientific; Guerbet; Quantum Surgical
 
Richard S. Finn
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; CStone Pharmaceuticals; Eisai; Exelixis; Genentech/Roche; Lilly; Merck; Novartis; Pfizer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Expert Testimony - Bayer
 
Sadahisa Ogasawara
Honoraria - Bayer; Chugai Pharma; Eisai; Lilly; Merck
Consulting or Advisory Role - AstraZeneca; Bayer; Chugai Pharma; Lilly; Merck
Research Funding - AstraZeneca; Bayer; Chugai Pharma; Eisai; Lilly
 
Zhenggang Ren
No Relationships to Disclose
 
Kalgi Mody
Employment - Eisai; Eisai
Travel, Accommodations, Expenses - Eisai; Eisai
 
Jerry J. Li
Employment - Bristol-Myers Squibb (I); Merck
Stock and Other Ownership Interests - Bristol-Myers Squibb (I); Merck
 
Abby B. Siegel
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Leonid Dubrovsky
Employment - Merck Sharp & Dohme
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Masatoshi Kudo
Honoraria - Bayer; Bristol-Myers Squibb Japan; EA Pharma; Eisai; Lilly Japan; MSD
Consulting or Advisory Role - BMS; Eisai; MSD; Ono Pharmaceutical; Roche
Research Funding - Abbvie (Inst); EA Pharma (Inst); Eisai (Inst); Gilead Sciences (Inst); Ono Pharmaceutical; Otsuka (Inst); Sumitomo Dainippon (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)